GRAS Path Draws Interest As New Dietary Ingredient Alternative, But Carries Challenges
This article was originally published in The Pink Sheet Daily
In the wake of FDA’s draft guidance on NDI notifications, more companies reevaluate the status of their ingredients before going to market. The GRAS for use in foods process is a clear – but rigorous – alternative pathway.
You may also be interested in...
History of use, toxicology studies key
FDA should clarify its criteria for rejecting generally recognized as safe notifications for food ingredients voluntarily submitted by companies, a consulting firm tells the agency.